相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。SARS-CoV-2 (COVID-19) Vaccine Development and Production: An Ethical Way Forward
Kenneth Iserson
CAMBRIDGE QUARTERLY OF HEALTHCARE ETHICS (2021)
Polymeric nanoparticle vaccines to combat emerging and pandemic threats
David Wibowo et al.
BIOMATERIALS (2021)
Development of a portable MIP-based electrochemical sensor for detection of SARS-CoV-2 antigen
Abdul Raziq et al.
BIOSENSORS & BIOELECTRONICS (2021)
COVID-19 vaccines: where we stand and challenges ahead
Guido Forni et al.
CELL DEATH AND DIFFERENTIATION (2021)
Looking beyond COVID-19 vaccine phase 3 trials
Jerome H. Kim et al.
NATURE MEDICINE (2021)
SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice
Jing-Hui Tian et al.
NATURE COMMUNICATIONS (2021)
Nanoparticles as Adjuvants and Nanodelivery Systems for mRNA-Based Vaccines
Iman M. Alfagih et al.
PHARMACEUTICS (2021)
Non-viral COVID-19 vaccine delivery systems
Kyung Soo Park et al.
ADVANCED DRUG DELIVERY REVIEWS (2021)
COVID-19 vaccines: The status and perspectives in delivery points of view
Jee Young Chung et al.
ADVANCED DRUG DELIVERY REVIEWS (2021)
Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment
Olivier J. Wouters et al.
LANCET (2021)
Sputnik V COVID-19 vaccine candidate appears safe and effective Comment
Ian Jones et al.
LANCET (2021)
DNA vaccines against COVID-19: Perspectives and challenges
Marcelle Moura Silveira et al.
LIFE SCIENCES (2021)
mRNA vaccine: a potential therapeutic strategy
Yang Wang et al.
MOLECULAR CANCER (2021)
Covid-19 vaccine passports: access, equity, and ethics
Tasnime Osama et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
Novel and emerging mutations of SARS-CoV-2: Biomedical implications
Elmira Mohammadi et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Computational Design of a Potential Therapeutic Peptide Against Spike Protein of SARS-CoV-2
Abbas Alibakhshi et al.
JOURNAL OF COMPUTATIONAL BIOPHYSICS AND CHEMISTRY (2021)
Computers and viral diseases. Preliminary bioinformatics studies on the design of a synthetic vaccine and a preventative peptidomimetic antagonist against the SARS-CoV-2 (2019-nCoV, COVID-19) coronavirus
B. Robson
COMPUTERS IN BIOLOGY AND MEDICINE (2020)
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
Roujian Lu et al.
LANCET (2020)
A new coronavirus associated with human respiratory disease in China
Fan Wu et al.
NATURE (2020)
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou et al.
NATURE (2020)
A codon-pair deoptimized live-attenuated vaccine against respiratory syncytial virus is immunogenic and efficacious in non-human primates
Steffen Mueller et al.
VACCINE (2020)
Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies
Syed Faraz Ahmed et al.
VIRUSES-BASEL (2020)
Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses
Michael Letko et al.
NATURE MICROBIOLOGY (2020)
Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review
Junxiong Pang et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Opportunities and Challenges in the Delivery of mRNA-Based Vaccines
Abishek Wadhwa et al.
PHARMACEUTICS (2020)
The outbreak of SARS-CoV-2 pneumonia calls for viral vaccines
Weilong Shang et al.
NPJ VACCINES (2020)
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
Alexandra C. Walls et al.
CELL (2020)
The Challenges of Vaccine Development against a New Virus during a Pandemic
Michael S. Diamond et al.
CELL HOST & MICROBE (2020)
Epidemiological, clinical characteristics of cases of SARS-CoV-2 infection with abnormal imaging findings
Xiaoli Zhang et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
Towards effective COVID-19 vaccines: Updates, perspectives and challenges (Review)
Daniela Calina et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2020)
Platelet functions and activities as potential hematologic parameters related to Coronavirus Disease 2019 (Covid-19)
Francesca Salamanna et al.
PLATELETS (2020)
Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells
Shutoku Matsuyama et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow
Behnood Bikdeli et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Potential of heparin and nafamostat combination therapy for COVID-19
Hidesaku Asakura et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
Fei Zhou et al.
LANCET (2020)
CAN THE WORLD MAKE ENOUGH CORONAVIRUS VACCINE?
Roxanne Khamsi
NATURE (2020)
The proximal origin of SARS-CoV-2
Kristian G. Andersen et al.
NATURE MEDICINE (2020)
Developing Covid-19 Vaccines at Pandemic Speed
Nicole Lurie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19
Muthiah Vaduganathan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Hyperinflammation and derangement of renin-angiotensin-aldosterone system in COVID-19: A novel hypothesis for clinically suspected hypercoagulopathy and microvascular immunothrombosis
Brandon Michael Henry et al.
CLINICA CHIMICA ACTA (2020)
Emerging vaccine delivery systems for COVID-19 Functionalised silica nanoparticles offer a potentially safe and effective alternative delivery system for DNA/RNA vaccines and may be useful in the hunt for a COVID-19 vaccine
Nigel Theobald
DRUG DISCOVERY TODAY (2020)
Targeting the Immune System for Pulmonary Inflammation and Cardiovascular Complications in COVID-19 Patients
Serena Colafrancesco et al.
FRONTIERS IN IMMUNOLOGY (2020)
Evidence for SARS-CoV-2 Infection of Animal Hosts
Ahmed S. Abdel-Moneim et al.
PATHOGENS (2020)
Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial
Feng-Cai Zhu et al.
LANCET (2020)
Why and How Vaccines Work
Akiko Iwasaki et al.
CELL (2020)
COVID-19 vaccine development and a potential nanomaterial path forward
Matthew D. Shin et al.
NATURE NANOTECHNOLOGY (2020)
An mRNA Vaccine against SARS-CoV-2-Preliminary Report
L. A. Jackson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Facilitating Access to a COVID-19 Vaccine through Global Health Law
Lawrence O. Gostin et al.
JOURNAL OF LAW MEDICINE & ETHICS (2020)
A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity
Angkana T. Huang et al.
NATURE COMMUNICATIONS (2020)
FDA approved drugs with pharmacotherapeutic potential for SARS-CoV-2 (COVID-19) therapy
Sylwester Drozdzal et al.
DRUG RESISTANCE UPDATES (2020)
Coronavirus vaccine development: from SARS and MERS to COVID-19
Yen-Der Li et al.
JOURNAL OF BIOMEDICAL SCIENCE (2020)
Immunological considerations for COVID-19 vaccine strategies
Mangalakumari Jeyanathan et al.
NATURE REVIEWS IMMUNOLOGY (2020)
COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation
Wolfgang Miesbach et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2020)
SARS-CoV-2 in fruit bats, ferrets, pigs, and chickens: an experimental transmission study
Kore Schlottau et al.
LANCET MICROBE (2020)
From COVID-19 research to vaccine application: why might it take 17 months not 17 years and what are the wider lessons?
Stephen R. Hanney et al.
HEALTH RESEARCH POLICY AND SYSTEMS (2020)
Efficacy of an Adjuvanted Middle East Respiratory Syndrome Coronavirus Spike Protein Vaccine in Dromedary Camels and Alpacas
Danielle R. Adney et al.
VIRUSES-BASEL (2019)
Human Coronavirus: Host-Pathogen Interaction
To Sing Fung et al.
ANNUAL REVIEW OF MICROBIOLOGY, VOL 73 (2019)
Middle East Respiratory Syndrome Vaccine Candidates: Cautious Optimism
Craig Schindewolf et al.
VIRUSES-BASEL (2019)
Development of Middle East Respiratory Syndrome Coronavirus vaccines - advances and challenges
Heeyoun Cho et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2018)
mRNA vaccines - a new era in vaccinology
Norbert Pardi et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
New Vaccine Technologies to Combat Outbreak Situations
Susanne Rauch et al.
FRONTIERS IN IMMUNOLOGY (2018)
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices-United States, 2018-19 Influenza Season
Lisa A. Grohskopf et al.
MMWR RECOMMENDATIONS AND REPORTS (2018)
Understanding modern-day vaccines: what you need to know
Volker Vetter et al.
ANNALS OF MEDICINE (2018)
Receptor-binding domain of MERS-CoV with optimal immunogen dosage and immunization interval protects human transgenic mice from MERS-CoV infection
Yufei Wang et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2017)
A generic screening platform for inhibitors of virus induced cell fusion using cellular electrical impedance
Daniel Watterson et al.
SCIENTIFIC REPORTS (2016)
Adenoviral vector-based strategies against infectious disease and cancer
Chao Zhang et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2016)
The costs and effectiveness of large Phase III pre-licensure vaccine clinical trials
Steven Black
EXPERT REVIEW OF VACCINES (2015)
Severe Acute Respiratory Syndrome Coronaviruses with Mutations in the E Protein Are Attenuated and Promising Vaccine Candidates
Jose A. Regla-Nava et al.
JOURNAL OF VIROLOGY (2015)
A decade after SARS: strategies for controlling emerging coronaviruses
Rachel L. Graham et al.
NATURE REVIEWS MICROBIOLOGY (2013)
Immunogenicity and Protection Efficacy of Monomeric and Trimeric Recombinant SARS Coronavirus Spike Protein Subunit Vaccine Candidates
Jie Li et al.
VIRAL IMMUNOLOGY (2013)
Tolerability of intramuscular and intradermal delivery by CELLECTRA® adaptive constant current electroporation device in healthy volunteers
Malissa C. Diehl et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)
Adjuvants for human vaccines
Carl R. Alving et al.
CURRENT OPINION IN IMMUNOLOGY (2012)
Artificial Molecular Clamp: A Novel Device for Synthetic Polymerases
Yoshinori Takashima et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2011)
Antigenicity and immunogenicity of SARS-CoV S protein receptor-binding domain stably expressed in CHO cells
Lanying Du et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
SARS vaccines: where are we?
Rachel L. Roper et al.
EXPERT REVIEW OF VACCINES (2009)
IMVAMUNE (R): modified vaccinia Ankara strain as an attenuated smallpox vaccine
Jeffrey S. Kennedy et al.
EXPERT REVIEW OF VACCINES (2009)
Novel adenovirus vaccine vectors based on the enteric-tropic serotype 41
Franck Lemiale et al.
VACCINE (2007)
Ii-Key/MHC class II apitope hybrids: a strategy that enhances MHC class II epitope loading to create more potent peptide vaccines
Nikoletta L. Kallinteris et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2006)
Generation and characterization of DNA vaccines targeting the nucleocapsid protein of severe acute respiratory syndrome coronavirus
TW Kim et al.
JOURNAL OF VIROLOGY (2004)
分享论文
